[{"Assets_0_Q3_USD":137527000.0,"CommonStockSharesOutstanding_0_Q3_shares":44520000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-10333000.0,"NetIncomeLoss_1_Q3_USD":3470000.0,"NetIncomeLoss_3_Q3_USD":-19166000.0,"StockholdersEquity_0_Q3_USD":96990000.0,"EarningsPerShareBasic_1_Q3_USD":0.08,"EarningsPerShareBasic_3_Q3_USD":-0.44,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":44251000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":43979000.0,"Ticker":"VCEL","CIK":"887359","name":"VERICEL CORP","OfficialName":"Vericel Corporation Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1756775066.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20191105"}]